https://european-biotechnology.net/wp-content/uploads/2025/10/tubulis_linker_ADC_web.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-15 09:08:402025-10-15 09:08:40Tubulis secures €308m in record-breaking Series C financing
https://european-biotechnology.net/wp-content/uploads/2025/10/Mianzbiomed-47-1-e1760519293304-1030x579-1.png5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-12 09:08:372025-10-12 09:08:37Blood test detects pancreatic cancer early
https://european-biotechnology.net/wp-content/uploads/2025/10/cq5dam.web_.1200.Jon-picture-cropped-2-1030x510-1.jpg5101030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-11 09:34:022025-10-11 09:34:02AstraZeneca agrees to MFN price reductions with US government
https://european-biotechnology.net/wp-content/uploads/2025/10/Ersatzbild_PSX_20251007_100334-e1759837974415-1030x580-1.jpg5801030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-07 08:37:572025-10-10 11:02:03BioSpain 2025 starts with new records
https://european-biotechnology.net/wp-content/uploads/2025/10/owlstone-web-breath.jpeg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-07 06:11:552025-10-10 11:02:03British Owlstone Medical wins ARPA-H award, but will it materialize?
https://european-biotechnology.net/wp-content/uploads/2025/10/Roche-Diagnostics-HQ-e1759728768320-1030x579-1.jpg5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-06 05:41:372025-10-10 11:02:03Roche gets CE mark for chronic kidney disease algorithm
